Role of surgery in patients with stage IV melanoma

Current Opinion in Oncology

Volumn 16, Issue 2, 2004, Pages 155-160

  Wong, Sandra L ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Melanoma; Metastasis; Palliation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FAMILY; HUMAN; LIFE EXPECTANCY; LUNG METASTASIS; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MELANOMA; METASTASIS; OUTCOMES RESEARCH; PATIENT; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; TREATMENT PLANNING; VISCERAL METASTASIS;

BRAIN NEOPLASMS; DECISION MAKING; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MELANOMA; NEOPLASM STAGING; PALLIATIVE CARE; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1642447037     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200403000-00013     Document Type: Review

References (53)

1. Reintgen DS, Vollmer R, Tso CY, Seigler HF: Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987, 122:1338-1342.
2. Allen PJ, Coit DG: The surgical management of metastatic melanoma. Ann Surg Oncol 2002, 9:762-770.
3. Allen PJ, Coit DG: The role of surgery for patients with metastatic melanoma. Curr Opin Oncol 2002, 14:221-226.
4. Balch CM, Buzaid AC, Soong SJ, et al.: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
5. Balch CM, Soong SJ, Gershenwald JE, et al.: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19:3622-3634. Outstanding collaborative effort which represents an analysis of 17,600 patients as part of the validation of the new AJCC staging system for melanoma
6. Miner TJ, Jaques DP, Shriver CD: A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol 2002, 9:696-703. Important study evaluating the relations between patient, family, and surgeon in the palliative phase of treatment for cancer. It introduces the concept of the palliation triangle.
7. Morton DL: Cytoreductive surgery and adjuvant immunotherapy in the management of metastatic melanoma. Tumori 2001, 87:557-559.
8. Garbe C, Paul A, Kohler-Spath H, et al.: Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003, 21:520-529. Recent prospective trial which examines follow-up procedures in over 2000 patients.
9. Stas M, Stroobants S, Dupont P, et al.: 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact. Melanoma Res 2002, 12:479-490. Examines utility of PET scanning in the context of other imaging studies, including false-positive and false-negative results.
10. Dalrymple-Hay MRJ, Rome PD, Kennedy C, et al.: Pulmonary metastatic melanoma-the survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg 2002, 21:611-615.
11. Swetter SM, Carroll LA, Johnson DL, et al.: Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 2002, 9:646-653. Recent retrospective study finds that PET has increased sensitivity over CT for occult metastatic disease.
12. Cobben DCP, Koopal S, Tiebosch ATMG, et al.: New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma. EJSO 2002, 28:692-700. Recent review article is a good update on staging techniques in melanoma.
13. Mijnhout GS, Hoekstra OS, vanLingen A, et al.: How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma. J Clin Path 2003, 56:283-286. Recent study which highlights the lower limits of resolution with PET scanning.
14. Spieth K, Risse J, Kaufmann R, et al.: Positron emission tomography scan mimicking lymph node metastases in a high-risk melanoma patient. J Clin Oncol 2002, 20:3344-3351.
15. Balch CM, Soong SJ, Murad TM, et al.: A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983, 1:126-134.
16. Markowitz JS, Cosimi LA, Carey RW, et al.: Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991, 126:703-707.
17. Gadd MA, Coit DG: Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992, 127:1412-1416.
18. Karakousis CP, Velez A, Driscoll BA, et al.: Metastasectomy in malignant melanoma. Surgery 1994, 115:295-302.
19. Barth A, Wanek LA, Morton DL: Prognostic factors in 1521 melanoma patients with distant metastases. J Am Coll Surg 1995, 181:193-201.
20. Eton O, Legha SS, Moon TE, et al.: Prognostic factors for survival of patients treated systematically disseminated melanoma. J Clin Oncol 1998, 16:1103-1111.
21. Meyer T, Merkel S, Goehl J, et al.: Surgical therapy for distant metastases of malignant melanoma. Cancer 2000, 89:1983-1991.
22. Bowen GM, Chang AE, Lowe L, et al.: Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol 2000, 136:1397-1399.
23. Karp NS, Boyd A, DePan HJ, et al.: Thoracotomy for metastatic malignant melanoma of the lung. Surgery 1990, 107:256-261.
24. Gorenstein LA, Putnam JB, Natarajan G, et al.: Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg 1991, 52:204-210.
25. Harpole DH, Johnson CM, Wolfe WG, et al.: Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992, 103:743-748.
26. Tafra L, Dale PS, Wanek LA, et al.: Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 1995, 110:119-128.
27. Leo F, Cagini L, Rocmans P, et al.: Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer 2000, 83:569-57.
28. Carlson JA: Tumor doubling time of cutaneous melanoma and its metastasis. Am J Dermatopath 2003, 25:291-299.
29. Mingione V, Oliveira M, Prasad D, et al.: Gamma surgery for melanoma metastases in the brain. J Neurosurg 2002, 96:544-551.
30. Grob JJ, Regis J, Laurans R, et al.: Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Eur J Cancer 1998, 34:1187-1192.
31. Yu C, Chen JCT, Apuzzo MLJ, et al.: Metastatic melanoma to the brain: Prognostic factors after gamma knife radiosurgery. Int J Radiation Oncology Biol Phys 2002, 52:1277-1287. Contemporary series which reports prognostic factors in patients with metastatic melanoma to the brain undergoing stereotactic radiotherapy.
32. Sampson JH, Carter JH, Friedman AH, Seigler HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11-20.
33. Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000, 93:9-18.
34. Skibber JM, Soong SJ, Austin L, et al.: Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996, 3:118-123.
35. Brown PD, Brown CA, Pollock BE, et al.: Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 2002, 51:656-667. Examines the use of stereotactic radiotherapy for brain metastases at a single institution; Includes a nice review of previous results with stereotactic radiotherapy in melanoma patients.
36. Gerosa M, Nicolato A, Foroni R: The role of gamma knife radiosurgery in the treatment of primary and metastatic brain tumors. Curr Opin Oncol 2003, 15:188-196. Excellent review of the current status of gamma knife radiosurgery in the treatment of brain tumors. Provides an overview of many of the articles included in the present review.
37. Buchsbaum JC, Suh JH, Lee SY, et al.: Survival by Radiation Therapy Oncology Group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma. Cancer 2002 94:2265-2272. Retrospective study which finds that the recursive partitioning analysis (RPA) used by the Radiation Therapy Oncology Group (RTOG) has prognostic value for patients with brain metastases from melanoma.
38. Hagen NA, Cirrincione C, Thaler HT, et al.: The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990, 40:158-160.
39. Saha S, Meyer M, Krementz ET, et al.: Prognostic evaluation of intracranial metastasis in malignant melanoma. Ann Surg Oncol 1994, 1:38-44.
40. Salvati M, Cervoni L, Caruso R, et al.: Solitary cerebral metastasis from melanoma: value of the 'en bloc' resection. Clin Neurol Neurosurg 1996, 98:12-14.
41. Panagiotou I, Brountzos EN, Bafaloukos D, et al.: Malignant melanoma metastatic to the gastrointestinal tract. Melanoma Res 2002, 12:169-173.
42. Ricaniadis N, Konstadoulakis MM, Walsh D, et al.: Gastrointestinal metastases from malignant melanoma. Surg Oncol 1995, 4:105-110.
43. Klasse JM, Kroon BB: Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg 1990, 77:60-61.
44. Khadra MH, Thompson JF, Milton GW, et al.: The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract. Surg Gynecol Obstet 1990, 171:413-416.
45. Ihde JK, Coit DG: Melanoma metastatic to stomach, small bowel, or colon. Am J Surg 1991, 162:208-211.
46. Caputy GG, Donohue JH, Goellner JR, et al.: Metastatic melanoma of the gastrointestinal tract. Results of surgical management. Arch Surg 1991, 126:1353-1358.
47. Ollila DW, Essner R, Wanek LA, et al.: Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996, 131:975-979.
48. Agrawal S, Yao TJ, Coit DG: Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 1999, 6:336-344.
49. Gutman H, Hess KR, Kokotsakis JA, et al.: Surgery for abdominal metastases of cutaneous melanoma. World J Surg 2001, 25:750-758.
50. Tessier DJ, McConnell EJ, Young-Fadok T, et al.: Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum 2003, 46:441-447. Case series report on colon metastases from melanoma, which includes a thorough review of the past literature.
51. De Wilt JH, McCarthy WH, Thompson JF: Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg 2003, 197:38-43. Recent report from the Sydney Melanoma Unit on their experience with splenic metastases from melanoma.
52. Rose DM, Essner R, Hughes TS, et al.: Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001, 136:950-955.
53. Manner G, Hartling MT, Russo P, et al.: Surgical management of metastatic melanoma to the ventricle. Tex Heart Inst J 2003, 30:218-220. Small case series which discusses the rare entity of intracardiac metastases from melanoma.